Design, synthesis and neuroprotective biological evaluation of novel HDAC6 inhibitors incorporating benzothiadiazinyl systems as cap groups

Documenti analoghi

• Design, synthesis, and biological evaluation of novel quinoxaline aryl ethers as anticancer agents
  di: Srinuvasu Nakka, et al.
  Pubblicazione: (2024)
• Discovering novel derivatives of STAT3 and HDAC inhibitors with anti‐tumor activity
  di: Yu Yang, et al.
  Pubblicazione: (2024)
• Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease
  di: Efe Doğukan Dincel, et al.
  Pubblicazione: (2024)
• Discovery of novel chromone and acrylate‐based pancreatic lipase inhibitors: Molecular modelling, synthesis, and in vitro evaluation for the treatment of obesity
  di: Prashant S. Auti, et al.
  Pubblicazione: (2024)
• Integrative analysis of ex vivo studies and microarray reveals the novel inhibitor effects of trehalose on the pathogenesis of pterygium
  di: Yasin Durkal, et al.
  Pubblicazione: (2024)